317 related articles for article (PubMed ID: 32865802)
1. Implementation of a Framework for an Abridged Review Using Good Reliance Practices: Optimising the Medicine Regulatory Review Process in South Africa.
Keyter A; Salek S; McAuslane N; Banoo S; Azatyan S; Walker S
Ther Innov Regul Sci; 2020 Sep; 54(5):1199-1207. PubMed ID: 32865802
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities.
Danks L; Semete-Makokotlela B; Otwombe K; Parag Y; Walker S; Salek S
Front Med (Lausanne); 2023; 10():1265058. PubMed ID: 37937144
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities.
Sithole T; Mahlangu G; Salek S; Walker S
Ther Innov Regul Sci; 2021 May; 55(3):474-489. PubMed ID: 33387356
[TBL] [Abstract][Full Text] [Related]
4. The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System.
Keyter A; Gouws J; Salek S; Walker S
Ther Innov Regul Sci; 2018 Jul; 52(4):449-458. PubMed ID: 29848046
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities.
McAuslane N; Bujar M; Sithole T; Ngum N; Owusu-Asante M; Walker S
Pharmaceut Med; 2023 May; 37(3):251-260. PubMed ID: 37074548
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients' Access to Medicines.
Keyter A; Salek S; Gouws J; Banoo S; Walker S
Ther Innov Regul Sci; 2020 Jul; 54(4):878-887. PubMed ID: 32557310
[TBL] [Abstract][Full Text] [Related]
7. Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices.
Rahalkar H; Sheppard A; Salek S
Front Pharmacol; 2021; 12():711361. PubMed ID: 34434109
[No Abstract] [Full Text] [Related]
8. Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Padayachee S; Sehloho T; Khea A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
Front Med (Lausanne); 2021; 8():742181. PubMed ID: 34513893
[No Abstract] [Full Text] [Related]
9. The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland.
Keyter A; Salek S; Banoo S; Walker S
Front Pharmacol; 2019; 10():228. PubMed ID: 30923501
[No Abstract] [Full Text] [Related]
10. Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients' Access to Medicines.
Koyuncu O; Gursoz H; Alkan A; Cetintas HC; Pasaoglu T; Mashaki Ceyhan E; Walker S
Front Pharmacol; 2019; 10():1557. PubMed ID: 32116658
[TBL] [Abstract][Full Text] [Related]
11. A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency.
Keyter A; Salek S; Banoo S; Walker S
Int J Health Policy Manag; 2022 Jun; 11(6):795-809. PubMed ID: 33300773
[TBL] [Abstract][Full Text] [Related]
12. Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries.
Shabangu PP; Kuwana RJ; Dube A
Front Med (Lausanne); 2022; 9():975032. PubMed ID: 36160156
[TBL] [Abstract][Full Text] [Related]
13. South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access.
Keyter A; Salek S; Danks L; Nkambule P; Semete-Makokotlela B; Walker S
Front Pharmacol; 2021; 12():699063. PubMed ID: 34366850
[No Abstract] [Full Text] [Related]
14. Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Danks L; Nkambule P; Juma A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
Front Med (Lausanne); 2021; 8():742200. PubMed ID: 34513894
[No Abstract] [Full Text] [Related]
15. The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore.
Haqaish WSA; Obeidat H; Patel P; Walker S
Pharmaceut Med; 2017; 31(1):21-30. PubMed ID: 28572733
[TBL] [Abstract][Full Text] [Related]
16. The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore.
Hashan H; Aljuffali I; Patel P; Walker S
Pharmaceut Med; 2016; 30():37-47. PubMed ID: 26834481
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Performance of the Gulf Cooperation Council Centralised Regulatory Review Process: Strategies to Improve Product Authorisation Efficiency and Quality.
Hashan HM; Al-Muteb SK; Alismail IA; Alsaleh ON; Alkherb ZM; McAuslane N; Walker SR
Pharmaceut Med; 2022 Aug; 36(4):223-231. PubMed ID: 35767216
[TBL] [Abstract][Full Text] [Related]
18. Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022.
Moeti L; Litedu M; Joubert J
J Pharm Policy Pract; 2023 Mar; 16(1):34. PubMed ID: 36864490
[TBL] [Abstract][Full Text] [Related]
19. The Turkish Medicines and Medical Devices Agency: Comparison of Its Registration Process with Australia, Canada, Saudi Arabia, and Singapore.
Mashaki Ceyhan E; Gürsöz H; Alkan A; Coşkun H; Koyuncu O; Walker S
Front Pharmacol; 2018; 9():9. PubMed ID: 29422861
[No Abstract] [Full Text] [Related]
20. The South African Regulatory System: Past, Present, and Future.
Keyter A; Banoo S; Salek S; Walker S
Front Pharmacol; 2018; 9():1407. PubMed ID: 30618735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
